You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Claims for Patent: 8,871,194


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,871,194
Title:Method for transforming a hair follicle
Abstract: To provide a transformed hair follicle and a method for transferring a gene to a mammal by means of the transformed hair follicle. The invention provides a method for producing a transformed hair follicle including transferring a gene into a hair follicle by use of a virus vector, characterized by including providing a lentivirus pseudo-typed with VSV-G as a virus vector and transfecting a hair follicle with the lentivirus ex vivo.
Inventor(s): Hachiya; Akira (Cincinnati, OH), Sriwiriyanont; Penkanok (Cincinnati, OH)
Assignee: Kao Corporation (Tokyo, JO)
Application Number:12/010,426
Patent Claims:1. A method of transforming a hair follicle stem cell, the method comprising: (a) collecting a tissue sample containing a hair follicle from the skin of a mammal; (b) trimming the tissue so that said sample consists essentially of a hair follicle; (c) contacting the tissue of step (b) with a VSV-G pseudo-typed lentiviral vector in the absence of a collagenase treatment, wherein the lentiviral vector comprises an exogenous gene; and (d) culturing the tissue of step (c) in hair follicular organ culture medium such that a hair follicle stem cell in the bulge region of the hair follicle is transformed and expresses the exogenous gene.

2. The method of claim 1, wherein the mammal is human.

3. A method of transferring a gene into a mammal, the method comprising: (a) collecting a tissue sample containing a hair follicle from the skin of a mammal; (b) trimming the tissue so that said sample consists essentially of a hair follicle; (c) contacting the tissue of step (b) with a VSV-G pseudo-typed lentiviral vector in the absence of collagenase treatment, wherein the lentiviral vector comprises an exogenous gene; (d) culturing the tissue of step (c) in hair follicular organ culture medium such that a hair follicle stem cell in the bulge region of the hair follicle is transformed and expresses the exogenous gene; and (e) transplanting the transformed hair follicle of step d) into a recipient mammal.

4. The method according to claim 3, wherein the hair follicle is of human origin.

5. A method for determining whether a transfected gene changes the shape or property of hair, the method comprising: (a) collecting a tissue sample containing a hair follicle from the skin of a mammal; (b) trimming the tissue so that said sample consists essentially of a hair follicle; (c) contacting the tissue of step (b) with a VSV-G pseudo-typed lentiviral vector in the absence of collagenase treatment, wherein the lentiviral vector comprises an exogenous gene; and (d) culturing the tissue of step (c) in hair follicular organ culture medium such that a hair follicle stem cell in the bulge region of the hair follicle is transformed and expresses the exogenous gene; (e) transplanting the transformed hair follicle of step d) into a recipient mammal; and (f) determining whether the expression of said gene changes the shape or property of the hair.

6. The method of claim 1, wherein (c) and (d) are performed 2 or 3 times.

7. The method of claim 1 or 3, wherein expression of said gene is detectable three months after transplantation of said transformed hair follicle.

8. The method of claim 5, wherein expression of said gene is detectable three months after transplantation of said transformed hair follicle.

9. The method of claim 5, wherein the hair follicle is of human origin.

10. The method of claim 1, 3, or 5, which results in the expression of said gene in hair follicle keratinocytes and melanocytes.

11. The method of claim 3 or 5, which results in the expression of said gene in a hair bulb of said recipient mammal.

12. The method of claim 2, 4, or 9, wherein the hair follicle is of human scalp origin.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.